Anaphylaxis: Highlights from the practice parameter update

Cleve Clin J Med. 2022 Feb 1;89(2):106-111. doi: 10.3949/ccjm.89a.21076.

Abstract

The practice parameter update on anaphylaxis from the Joint Task Force on Practice Parameters, with the collaboration of the American Academy of Allergy, Asthma, and Immunology and the American College of Allergy, Asthma, and Immunology, addresses key issues in the management and prevention of anaphylaxis. The updated guidelines define diagnostic criteria for anaphylaxis; therapeutic use of epinephrine, antihistamines, and glucocorticoids; prevention of recurrent anaphylaxis; and follow-up care that includes education on trigger avoidance and use of self-injectable epinephrine.

Publication types

  • Practice Guideline

MeSH terms

  • Anaphylaxis* / diagnosis
  • Anaphylaxis* / drug therapy
  • Epinephrine / therapeutic use
  • Glucocorticoids / therapeutic use
  • Humans
  • United States

Substances

  • Glucocorticoids
  • Epinephrine